[go: up one dir, main page]

AU1144097A - Ox-2 costimulatory molecule - Google Patents

Ox-2 costimulatory molecule

Info

Publication number
AU1144097A
AU1144097A AU11440/97A AU1144097A AU1144097A AU 1144097 A AU1144097 A AU 1144097A AU 11440/97 A AU11440/97 A AU 11440/97A AU 1144097 A AU1144097 A AU 1144097A AU 1144097 A AU1144097 A AU 1144097A
Authority
AU
Australia
Prior art keywords
costimulatory molecule
costimulatory
molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11440/97A
Inventor
Francescopaolo Borriello
Arlene H Sharpe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
Original Assignee
Brigham and Womens Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham and Womens Hospital Inc filed Critical Brigham and Womens Hospital Inc
Publication of AU1144097A publication Critical patent/AU1144097A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU11440/97A 1995-12-08 1996-11-27 Ox-2 costimulatory molecule Abandoned AU1144097A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US875495P 1995-12-08 1995-12-08
US008754 1995-12-08
PCT/US1996/019189 WO1997021450A1 (en) 1995-12-08 1996-11-27 Ox-2 costimulatory molecule

Publications (1)

Publication Number Publication Date
AU1144097A true AU1144097A (en) 1997-07-03

Family

ID=21733473

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11440/97A Abandoned AU1144097A (en) 1995-12-08 1996-11-27 Ox-2 costimulatory molecule

Country Status (2)

Country Link
AU (1) AU1144097A (en)
WO (1) WO1997021450A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6955811B2 (en) 1997-11-07 2005-10-18 Trillium Therapeutics Inc. Methods of inhibiting immune response suppression by administering antibodies to OX-2
ATE319825T1 (en) 1997-11-07 2006-03-15 Trillium Therapeutics Inc METHODS AND COMPOSITIONS FOR IMMUNOMODULATION
US7223729B2 (en) 1997-11-07 2007-05-29 Trillium Therapeutics Inc. Methods of treating allergy by administering a CD200 protein
EP1171154A2 (en) * 1999-04-13 2002-01-16 Schering Corporation Uses of mammalian ox2 protein and related reagents
US7408041B2 (en) 2000-12-08 2008-08-05 Alexion Pharmaceuticals, Inc. Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
US9249229B2 (en) 2000-12-08 2016-02-02 Alexion Pharmaceuticals, Inc. Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
US20060057651A1 (en) 2000-12-08 2006-03-16 Bowdish Katherine S Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
WO2002059280A2 (en) 2000-12-08 2002-08-01 Alexion Pharmaceuticals, Inc. Chronic lymphocytic leukemia cell line and its use for producing an antibody
AU2007207764B2 (en) 2006-01-12 2012-06-07 Alexion Pharmaceuticals, Inc. Antibodies to OX-2/CD200 and uses thereof
EP2185593B1 (en) * 2007-07-25 2017-12-13 Alexion Pharmaceuticals, Inc. Compositions for treating autoimmune disease
SG182408A1 (en) 2010-01-11 2012-08-30 Alexion Pharma Inc Biomarkers of immunomodulatory effects in humans treated with anti-cd200 antibodies
EP2534178A4 (en) 2010-02-11 2013-08-07 Alexion Pharma Inc Therapeutic methods using an ti-cd200 antibodies
WO2019067499A1 (en) 2017-09-27 2019-04-04 Alexion Pharmaceuticals, Inc. Biomarker signature for predicting tumor response to anti-cd200 therapy
WO2019126536A1 (en) 2017-12-20 2019-06-27 Alexion Pharmaceuticals Inc. Humanized anti-cd200 antibodies and uses thereof
US12139533B2 (en) 2017-12-20 2024-11-12 Alexion Pharmaceuticals, Inc. Liquid formulations of anti-CD200 antibodies

Also Published As

Publication number Publication date
WO1997021450A1 (en) 1997-06-19

Similar Documents

Publication Publication Date Title
AU5539596A (en) Anti-obesity agents
AU5235796A (en) o-hydroxyphenyl-s-triazines
AU6450496A (en) Chuck
AU4780896A (en) Core-board
AU6000496A (en) Phenylpyridazinones
AU5896396A (en) Pyridine-microbicides
AU1030997A (en) Taphane
AU4996696A (en) 2-benzyl-3-arylbenzothiophenes
AU1144097A (en) Ox-2 costimulatory molecule
AUPN178995A0 (en) Antigen composition
AU5147496A (en) Fucopeptides
AUPN088395A0 (en) Structural member
AU6235496A (en) Azothiophenes
AU5593896A (en) Benzisothiazolyl-substituted aminomethylchromans
AU4382896A (en) Acetylimidazobenzodiazepines
AU5500196A (en) Anti-transpirants
AU4942396A (en) Connecting component
AU6215196A (en) Piperidinylmethyloxazolidinones
AU5917896A (en) Poly-beta-1-4-N-acetylglucosamine
AU5013796A (en) Wireclamp
AU5107096A (en) Haemodialyser
AU6123996A (en) Device for connecting structural parts
AU4569496A (en) Tetralinyl- and indanyl-ethylamides
AU2609095A (en) Compartmentalizer
AU5878096A (en) Fasciotome